Concepedia
Statistics
Publications
9
Citations
816
H-Index
Active since
2010
Affiliations
University College London(Current)
NeRRe Therapeutics (United Kingdom)
Dana-Farber Cancer Institute
Harvard University
University of Perugia
Miriam Canavese is an author at University College London specializing in medicine, inflammation, and pharmacology.
Publications per year
2010–2025
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
Loredana Santo, Teru Hideshima, Andrew L. Kung et al. · Blood · 2012 · 601 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +15
Preclinical Activity of the Oral Proteasome Inhibitor MLN9708 in Myeloma Bone Disease
Antonio García-Gómez, Dalia Quwaider, Miriam Canavese et al. · Clinical Cancer Research · 2014 · 85 citations
Medicine, Oncology, Pharmacology +16
Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease
Jey M Jeyakumar, Azadeh Kia, Lawrence C. S. Tam et al. · Gene Therapy · 2023 · 38 citations · Full text
Life Sciences, Molecular Biology, Molecular Medicine +15
Therapeutic Efficacy and Immunological Response of CCL5 Antagonists in Models of Contact Skin Reaction
Miriam Canavese, Fiorella Altruda, Lorenzo Silengo · PLoS ONE · 2010 · 24 citations · Full text
Medicine, Dermatology, Immunology +17
Clinical, pathological and immunological features of psoriatic-like lesions affecting keratin 14-vascular endothelial growth factor transgenic mice.
Miriam Canavese, Fiorella Altruda, Lorenzo Silengo et al. · PubMed · 2011 · 18 citations · Full text
Medicine, Dermatology, Pathology +16
1–5 of 9